APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence in Drug Discovery

Compare research editions
View pricing & licenses

Selected research

Industry Research

Artificial Intelligence in Drug Discovery Industry Research Report 2026

5 January 2026142 pages

Choose your research edition.

Industry ResearchArtificial Intelligence in Drug Discovery Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence in Drug Discovery Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence in Drug Discovery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence in Drug Discovery Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence in Drug Discovery Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Artificial Intelligence in Drug Discovery market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Artificial Intelligence in Drug Discovery market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Artificial Intelligence in Drug Discovery market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Artificial Intelligence in Drug Discovery market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Artificial Intelligence in Drug Discovery include IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine and NVIDIA, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Artificial Intelligence in Drug Discovery market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Artificial Intelligence in Drug Discovery.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Artificial Intelligence in Drug Discovery Market by Company

IBM

Exscientia

Google(Alphabet)

Microsoft

Atomwise

Schrodinger

Aitia

Insilico Medicine

NVIDIA

XtalPi

BPGbio

Owkin

CytoReason

Deep Genomics

Cloud Pharmaceuticals

BenevolentAI

Cyclica

Verge Genomics

Valo Health

Envisagenics

Euretos

BioAge Labs

Iktos

BioSymetrics

Evaxion Biotech

Aria Pharmaceuticals, Inc

Artificial Intelligence in Drug Discovery Segment by Type

Hardware

Software

Service

Artificial Intelligence in Drug Discovery Segment by Application

Early Drug Discovery

Preclinical Phase

Clinical Phase

Regulatory Approval

Artificial Intelligence in Drug Discovery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence in Drug Discovery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence in Drug Discovery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence in Drug Discovery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Artificial Intelligence in Drug Discovery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Artificial Intelligence in Drug Discovery Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Type (2021-2026) Table 7. Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Type (2027-2032) Table 9. Global Artificial Intelligence in Drug Discovery Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Application (2021-2026) Table 11. Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Application (2027-2032) Table 13. Global Artificial Intelligence in Drug Discovery Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Artificial Intelligence in Drug Discovery Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Artificial Intelligence in Drug Discovery Market Share by Region (2021-2026) Table 16. Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Artificial Intelligence in Drug Discovery Market Share by Region (2027-2032) Table 18. Artificial Intelligence in Drug Discovery Industry Trends Table 19. Artificial Intelligence in Drug Discovery Industry Drivers Table 20. Artificial Intelligence in Drug Discovery Industry Opportunities and Challenges Table 21. Artificial Intelligence in Drug Discovery Market Restraints Table 22. Global Top Artificial Intelligence in Drug Discovery Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Artificial Intelligence in Drug Discovery Revenue Market Share by Players (2021-2026) Table 24. Global Artificial Intelligence in Drug Discovery Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Artificial Intelligence in Drug Discovery, Headquarters and Area Served Table 26. Global Artificial Intelligence in Drug Discovery Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Artificial Intelligence in Drug Discovery by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Artificial Intelligence in Drug Discovery Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Artificial Intelligence in Drug Discovery Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Artificial Intelligence in Drug Discovery Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Artificial Intelligence in Drug Discovery Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Artificial Intelligence in Drug Discovery Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Artificial Intelligence in Drug Discovery Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Artificial Intelligence in Drug Discovery Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Artificial Intelligence in Drug Discovery Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Artificial Intelligence in Drug Discovery Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Artificial Intelligence in Drug Discovery Market Size by Country (2027-2032) & (US$ Million) Table 45. IBM Company Information Table 46. IBM Business Overview Table 47. IBM Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 48. IBM Artificial Intelligence in Drug Discovery Product Portfolio Table 49. IBM Recent Developments Table 50. Exscientia Company Information Table 51. Exscientia Business Overview Table 52. Exscientia Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 53. Exscientia Artificial Intelligence in Drug Discovery Product Portfolio Table 54. Exscientia Recent Developments Table 55. Google(Alphabet) Company Information Table 56. Google(Alphabet) Business Overview Table 57. Google(Alphabet) Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 58. Google(Alphabet) Artificial Intelligence in Drug Discovery Product Portfolio Table 59. Google(Alphabet) Recent Developments Table 60. Microsoft Company Information Table 61. Microsoft Business Overview Table 62. Microsoft Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 63. Microsoft Artificial Intelligence in Drug Discovery Product Portfolio Table 64. Microsoft Recent Developments Table 65. Atomwise Company Information Table 66. Atomwise Business Overview Table 67. Atomwise Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 68. Atomwise Artificial Intelligence in Drug Discovery Product Portfolio Table 69. Atomwise Recent Developments Table 70. Schrodinger Company Information Table 71. Schrodinger Business Overview Table 72. Schrodinger Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 73. Schrodinger Artificial Intelligence in Drug Discovery Product Portfolio Table 74. Schrodinger Recent Developments Table 75. Aitia Company Information Table 76. Aitia Business Overview Table 77. Aitia Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 78. Aitia Artificial Intelligence in Drug Discovery Product Portfolio Table 79. Aitia Recent Developments Table 80. Insilico Medicine Company Information Table 81. Insilico Medicine Business Overview Table 82. Insilico Medicine Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 83. Insilico Medicine Artificial Intelligence in Drug Discovery Product Portfolio Table 84. Insilico Medicine Recent Developments Table 85. NVIDIA Company Information Table 86. NVIDIA Business Overview Table 87. NVIDIA Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 88. NVIDIA Artificial Intelligence in Drug Discovery Product Portfolio Table 89. NVIDIA Recent Developments Table 90. XtalPi Company Information Table 91. XtalPi Business Overview Table 92. XtalPi Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 93. XtalPi Artificial Intelligence in Drug Discovery Product Portfolio Table 94. XtalPi Recent Developments Table 95. BPGbio Company Information Table 96. BPGbio Business Overview Table 97. BPGbio Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 98. BPGbio Artificial Intelligence in Drug Discovery Product Portfolio Table 99. BPGbio Recent Developments Table 100. Owkin Company Information Table 101. Owkin Business Overview Table 102. Owkin Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 103. Owkin Artificial Intelligence in Drug Discovery Product Portfolio Table 104. Owkin Recent Developments Table 105. CytoReason Company Information Table 106. CytoReason Business Overview Table 107. CytoReason Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 108. CytoReason Artificial Intelligence in Drug Discovery Product Portfolio Table 109. CytoReason Recent Developments Table 110. Deep Genomics Company Information Table 111. Deep Genomics Business Overview Table 112. Deep Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 113. Deep Genomics Artificial Intelligence in Drug Discovery Product Portfolio Table 114. Deep Genomics Recent Developments Table 115. Cloud Pharmaceuticals Company Information Table 116. Cloud Pharmaceuticals Business Overview Table 117. Cloud Pharmaceuticals Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 118. Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Product Portfolio Table 119. Cloud Pharmaceuticals Recent Developments Table 120. BenevolentAI Company Information Table 121. BenevolentAI Business Overview Table 122. BenevolentAI Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 123. BenevolentAI Artificial Intelligence in Drug Discovery Product Portfolio Table 124. BenevolentAI Recent Developments Table 125. Cyclica Company Information Table 126. Cyclica Business Overview Table 127. Cyclica Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 128. Cyclica Artificial Intelligence in Drug Discovery Product Portfolio Table 129. Cyclica Recent Developments Table 130. Verge Genomics Company Information Table 131. Verge Genomics Business Overview Table 132. Verge Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 133. Verge Genomics Artificial Intelligence in Drug Discovery Product Portfolio Table 134. Verge Genomics Recent Developments Table 135. Valo Health Company Information Table 136. Valo Health Business Overview Table 137. Valo Health Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 138. Valo Health Artificial Intelligence in Drug Discovery Product Portfolio Table 139. Valo Health Recent Developments Table 140. Envisagenics Company Information Table 141. Envisagenics Business Overview Table 142. Envisagenics Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 143. Envisagenics Artificial Intelligence in Drug Discovery Product Portfolio Table 144. Envisagenics Recent Developments Table 145. Euretos Company Information Table 146. Euretos Business Overview Table 147. Euretos Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 148. Euretos Artificial Intelligence in Drug Discovery Product Portfolio Table 149. Euretos Recent Developments Table 150. BioAge Labs Company Information Table 151. BioAge Labs Business Overview Table 152. BioAge Labs Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 153. BioAge Labs Artificial Intelligence in Drug Discovery Product Portfolio Table 154. BioAge Labs Recent Developments Table 155. Iktos Company Information Table 156. Iktos Business Overview Table 157. Iktos Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 158. Iktos Artificial Intelligence in Drug Discovery Product Portfolio Table 159. Iktos Recent Developments Table 160. BioSymetrics Company Information Table 161. BioSymetrics Business Overview Table 162. BioSymetrics Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 163. BioSymetrics Artificial Intelligence in Drug Discovery Product Portfolio Table 164. BioSymetrics Recent Developments Table 165. Evaxion Biotech Company Information Table 166. Evaxion Biotech Business Overview Table 167. Evaxion Biotech Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 168. Evaxion Biotech Artificial Intelligence in Drug Discovery Product Portfolio Table 169. Evaxion Biotech Recent Developments Table 170. Aria Pharmaceuticals, Inc Company Information Table 171. Aria Pharmaceuticals, Inc Business Overview Table 172. Aria Pharmaceuticals, Inc Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026) & (US$ Million) Table 173. Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Product Portfolio Table 174. Aria Pharmaceuticals, Inc Recent Developments Table 175. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Artificial Intelligence in Drug Discovery Product Image Figure 5. Global Artificial Intelligence in Drug Discovery Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Artificial Intelligence in Drug Discovery Market Share by Type: 2025 VS 2032 Figure 7. Hardware Product Figure 8. Software Product Figure 9. Service Product Figure 10. Global Artificial Intelligence in Drug Discovery Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Artificial Intelligence in Drug Discovery Market Share by Application: 2025 VS 2032 Figure 12. Early Drug Discovery Product Figure 13. Preclinical Phase Product Figure 14. Clinical Phase Product Figure 15. Regulatory Approval Product Figure 16. Global Artificial Intelligence in Drug Discovery Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 17. Global Artificial Intelligence in Drug Discovery Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Artificial Intelligence in Drug Discovery Market Share by Region: 2025 VS 2032 Figure 19. Global Artificial Intelligence in Drug Discovery Market Share by Players in 2025 Figure 20. Global Artificial Intelligence in Drug Discovery Manufacturers Established Date Figure 21. Global Top 5 and 10 Artificial Intelligence in Drug Discovery Players Market Share by Revenue in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. North America Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Artificial Intelligence in Drug Discovery Market Share by Country (2021-2032) Figure 25. United States Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Canada Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Mexico Artificial Intelligence in Drug Discovery Market Share by Country (2021-2032) Figure 28. Europe Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Artificial Intelligence in Drug Discovery Market Share by Country (2021-2032) Figure 30. Germany Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. France Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. U.K. Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Italy Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Spain Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Russia Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Netherlands Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Nordic Countries Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Artificial Intelligence in Drug Discovery Market Share by Country (2021-2032) Figure 40. China Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Japan Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. South Korea Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India Artificial Intelligence in Drug Discovery Market Share by Country (2021-2032) Figure 45. Australia Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. China Taiwan Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Southeast Asia Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America Artificial Intelligence in Drug Discovery Market Share by Country (2021-2032) Figure 50. Brazil Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Argentina Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Chile Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Colombia Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Peru Artificial Intelligence in Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. IBM Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 56. Exscientia Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 57. Google(Alphabet) Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 58. Microsoft Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 59. Atomwise Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 60. Schrodinger Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 61. Aitia Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 62. Insilico Medicine Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 63. NVIDIA Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 64. XtalPi Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 65. BPGbio Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 66. Owkin Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 67. CytoReason Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 68. Deep Genomics Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 69. Cloud Pharmaceuticals Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 70. BenevolentAI Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 71. Cyclica Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 72. Verge Genomics Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 73. Valo Health Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 74. Envisagenics Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 75. Euretos Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 76. BioAge Labs Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 77. Iktos Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 78. BioSymetrics Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 79. Evaxion Biotech Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026) Figure 80. Aria Pharmaceuticals, Inc Revenue Growth Rate in Artificial Intelligence in Drug Discovery Business (2021-2026)

Scope & coverage.

Types
  • Hardware
  • Software
  • Service
Applications
  • Early Drug Discovery
  • Preclinical Phase
  • Clinical Phase
  • Regulatory Approval
Companies covered
  • IBM
  • Exscientia
  • Google(Alphabet)
  • Microsoft
  • Atomwise
  • Schrodinger
  • Aitia
  • Insilico Medicine
  • NVIDIA
  • XtalPi
  • BPGbio
  • Owkin
  • CytoReason
  • Deep Genomics
  • Cloud Pharmaceuticals
  • BenevolentAI
  • Cyclica
  • Verge Genomics
  • Valo Health
  • Envisagenics
  • Euretos
  • BioAge Labs
  • Iktos
  • BioSymetrics
  • Evaxion Biotech
  • Aria Pharmaceuticals, Inc

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Artificial Intelligence in Drug Discovery by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Hardware
  5. 2.2.3 Software
  6. 2.2.4 Service
  7. 2.3 Artificial Intelligence in Drug Discovery by Application
  8. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  9. 2.3.2 Early Drug Discovery
  10. 2.3.3 Preclinical Phase
  11. 2.3.4 Clinical Phase
  12. 2.3.5 Regulatory Approval
  13. 2.4 Assumptions and Limitations
3 Artificial Intelligence in Drug Discovery Breakdown Data by Type
  1. 3.1 Global Artificial Intelligence in Drug Discovery Historic Market Size by Type (2021-2026)
  2. 3.2 Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Type (2027-2032)
4 Artificial Intelligence in Drug Discovery Breakdown Data by Application
  1. 4.1 Global Artificial Intelligence in Drug Discovery Historic Market Size by Application (2021-2026)
  2. 4.2 Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Artificial Intelligence in Drug Discovery Market Perspective (2021-2032)
  2. 5.2 Global Artificial Intelligence in Drug Discovery Growth Trends by Region
  3. 5.2.1 Global Artificial Intelligence in Drug Discovery Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Artificial Intelligence in Drug Discovery Historic Market Size by Region (2021-2026)
  5. 5.2.3 Artificial Intelligence in Drug Discovery Forecasted Market Size by Region (2027-2032)
  6. 5.3 Artificial Intelligence in Drug Discovery Market Dynamics
  7. 5.3.1 Artificial Intelligence in Drug Discovery Industry Trends
  8. 5.3.2 Artificial Intelligence in Drug Discovery Market Drivers
  9. 5.3.3 Artificial Intelligence in Drug Discovery Market Challenges
  10. 5.3.4 Artificial Intelligence in Drug Discovery Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Artificial Intelligence in Drug Discovery Players by Revenue
  2. 6.1.1 Global Top Artificial Intelligence in Drug Discovery Players by Revenue (2021-2026)
  3. 6.1.2 Global Artificial Intelligence in Drug Discovery Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Artificial Intelligence in Drug Discovery Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Artificial Intelligence in Drug Discovery Head Office and Area Served
  6. 6.4 Global Artificial Intelligence in Drug Discovery Players, Product Type & Application
  7. 6.5 Global Artificial Intelligence in Drug Discovery Manufacturers Established Date
  8. 6.6 Global Artificial Intelligence in Drug Discovery Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Artificial Intelligence in Drug Discovery Market Size (2021-2032)
  2. 7.2 North America Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Artificial Intelligence in Drug Discovery Market Size by Country (2021-2026)
  4. 7.4 North America Artificial Intelligence in Drug Discovery Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Artificial Intelligence in Drug Discovery Market Size (2021-2032)
  2. 8.2 Europe Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Artificial Intelligence in Drug Discovery Market Size by Country (2021-2026)
  4. 8.4 Europe Artificial Intelligence in Drug Discovery Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size (2021-2032)
  2. 9.2 Asia-Pacific Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Artificial Intelligence in Drug Discovery Market Size (2021-2032)
  2. 10.2 South America Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Artificial Intelligence in Drug Discovery Market Size by Country (2021-2026)
  4. 10.4 South America Artificial Intelligence in Drug Discovery Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size (2021-2032)
  2. 11.2 Middle East & Africa Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 IBM
  2. 12.1.1 IBM Company Information
  3. 12.1.2 IBM Business Overview
  4. 12.1.3 IBM Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  5. 12.1.4 IBM Artificial Intelligence in Drug Discovery Product Portfolio
  6. 12.1.5 IBM Recent Developments
  7. 12.2 Exscientia
  8. 12.2.1 Exscientia Company Information
  9. 12.2.2 Exscientia Business Overview
  10. 12.2.3 Exscientia Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  11. 12.2.4 Exscientia Artificial Intelligence in Drug Discovery Product Portfolio
  12. 12.2.5 Exscientia Recent Developments
  13. 12.3 Google(Alphabet)
  14. 12.3.1 Google(Alphabet) Company Information
  15. 12.3.2 Google(Alphabet) Business Overview
  16. 12.3.3 Google(Alphabet) Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  17. 12.3.4 Google(Alphabet) Artificial Intelligence in Drug Discovery Product Portfolio
  18. 12.3.5 Google(Alphabet) Recent Developments
  19. 12.4 Microsoft
  20. 12.4.1 Microsoft Company Information
  21. 12.4.2 Microsoft Business Overview
  22. 12.4.3 Microsoft Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  23. 12.4.4 Microsoft Artificial Intelligence in Drug Discovery Product Portfolio
  24. 12.4.5 Microsoft Recent Developments
  25. 12.5 Atomwise
  26. 12.5.1 Atomwise Company Information
  27. 12.5.2 Atomwise Business Overview
  28. 12.5.3 Atomwise Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  29. 12.5.4 Atomwise Artificial Intelligence in Drug Discovery Product Portfolio
  30. 12.5.5 Atomwise Recent Developments
  31. 12.6 Schrodinger
  32. 12.6.1 Schrodinger Company Information
  33. 12.6.2 Schrodinger Business Overview
  34. 12.6.3 Schrodinger Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  35. 12.6.4 Schrodinger Artificial Intelligence in Drug Discovery Product Portfolio
  36. 12.6.5 Schrodinger Recent Developments
  37. 12.7 Aitia
  38. 12.7.1 Aitia Company Information
  39. 12.7.2 Aitia Business Overview
  40. 12.7.3 Aitia Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  41. 12.7.4 Aitia Artificial Intelligence in Drug Discovery Product Portfolio
  42. 12.7.5 Aitia Recent Developments
  43. 12.8 Insilico Medicine
  44. 12.8.1 Insilico Medicine Company Information
  45. 12.8.2 Insilico Medicine Business Overview
  46. 12.8.3 Insilico Medicine Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  47. 12.8.4 Insilico Medicine Artificial Intelligence in Drug Discovery Product Portfolio
  48. 12.8.5 Insilico Medicine Recent Developments
  49. 12.9 NVIDIA
  50. 12.9.1 NVIDIA Company Information
  51. 12.9.2 NVIDIA Business Overview
  52. 12.9.3 NVIDIA Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  53. 12.9.4 NVIDIA Artificial Intelligence in Drug Discovery Product Portfolio
  54. 12.9.5 NVIDIA Recent Developments
  55. 12.10 XtalPi
  56. 12.10.1 XtalPi Company Information
  57. 12.10.2 XtalPi Business Overview
  58. 12.10.3 XtalPi Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  59. 12.10.4 XtalPi Artificial Intelligence in Drug Discovery Product Portfolio
  60. 12.10.5 XtalPi Recent Developments
  61. 12.11 BPGbio
  62. 12.11.1 BPGbio Company Information
  63. 12.11.2 BPGbio Business Overview
  64. 12.11.3 BPGbio Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  65. 12.11.4 BPGbio Artificial Intelligence in Drug Discovery Product Portfolio
  66. 12.11.5 BPGbio Recent Developments
  67. 12.12 Owkin
  68. 12.12.1 Owkin Company Information
  69. 12.12.2 Owkin Business Overview
  70. 12.12.3 Owkin Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  71. 12.12.4 Owkin Artificial Intelligence in Drug Discovery Product Portfolio
  72. 12.12.5 Owkin Recent Developments
  73. 12.13 CytoReason
  74. 12.13.1 CytoReason Company Information
  75. 12.13.2 CytoReason Business Overview
  76. 12.13.3 CytoReason Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  77. 12.13.4 CytoReason Artificial Intelligence in Drug Discovery Product Portfolio
  78. 12.13.5 CytoReason Recent Developments
  79. 12.14 Deep Genomics
  80. 12.14.1 Deep Genomics Company Information
  81. 12.14.2 Deep Genomics Business Overview
  82. 12.14.3 Deep Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  83. 12.14.4 Deep Genomics Artificial Intelligence in Drug Discovery Product Portfolio
  84. 12.14.5 Deep Genomics Recent Developments
  85. 12.15 Cloud Pharmaceuticals
  86. 12.15.1 Cloud Pharmaceuticals Company Information
  87. 12.15.2 Cloud Pharmaceuticals Business Overview
  88. 12.15.3 Cloud Pharmaceuticals Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  89. 12.15.4 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Product Portfolio
  90. 12.15.5 Cloud Pharmaceuticals Recent Developments
  91. 12.16 BenevolentAI
  92. 12.16.1 BenevolentAI Company Information
  93. 12.16.2 BenevolentAI Business Overview
  94. 12.16.3 BenevolentAI Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  95. 12.16.4 BenevolentAI Artificial Intelligence in Drug Discovery Product Portfolio
  96. 12.16.5 BenevolentAI Recent Developments
  97. 12.17 Cyclica
  98. 12.17.1 Cyclica Company Information
  99. 12.17.2 Cyclica Business Overview
  100. 12.17.3 Cyclica Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  101. 12.17.4 Cyclica Artificial Intelligence in Drug Discovery Product Portfolio
  102. 12.17.5 Cyclica Recent Developments
  103. 12.18 Verge Genomics
  104. 12.18.1 Verge Genomics Company Information
  105. 12.18.2 Verge Genomics Business Overview
  106. 12.18.3 Verge Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  107. 12.18.4 Verge Genomics Artificial Intelligence in Drug Discovery Product Portfolio
  108. 12.18.5 Verge Genomics Recent Developments
  109. 12.19 Valo Health
  110. 12.19.1 Valo Health Company Information
  111. 12.19.2 Valo Health Business Overview
  112. 12.19.3 Valo Health Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  113. 12.19.4 Valo Health Artificial Intelligence in Drug Discovery Product Portfolio
  114. 12.19.5 Valo Health Recent Developments
  115. 12.20 Envisagenics
  116. 12.20.1 Envisagenics Company Information
  117. 12.20.2 Envisagenics Business Overview
  118. 12.20.3 Envisagenics Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  119. 12.20.4 Envisagenics Artificial Intelligence in Drug Discovery Product Portfolio
  120. 12.20.5 Envisagenics Recent Developments
  121. 12.21 Euretos
  122. 12.21.1 Euretos Company Information
  123. 12.21.2 Euretos Business Overview
  124. 12.21.3 Euretos Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  125. 12.21.4 Euretos Artificial Intelligence in Drug Discovery Product Portfolio
  126. 12.21.5 Euretos Recent Developments
  127. 12.22 BioAge Labs
  128. 12.22.1 BioAge Labs Company Information
  129. 12.22.2 BioAge Labs Business Overview
  130. 12.22.3 BioAge Labs Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  131. 12.22.4 BioAge Labs Artificial Intelligence in Drug Discovery Product Portfolio
  132. 12.22.5 BioAge Labs Recent Developments
  133. 12.23 Iktos
  134. 12.23.1 Iktos Company Information
  135. 12.23.2 Iktos Business Overview
  136. 12.23.3 Iktos Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  137. 12.23.4 Iktos Artificial Intelligence in Drug Discovery Product Portfolio
  138. 12.23.5 Iktos Recent Developments
  139. 12.24 BioSymetrics
  140. 12.24.1 BioSymetrics Company Information
  141. 12.24.2 BioSymetrics Business Overview
  142. 12.24.3 BioSymetrics Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  143. 12.24.4 BioSymetrics Artificial Intelligence in Drug Discovery Product Portfolio
  144. 12.24.5 BioSymetrics Recent Developments
  145. 12.25 Evaxion Biotech
  146. 12.25.1 Evaxion Biotech Company Information
  147. 12.25.2 Evaxion Biotech Business Overview
  148. 12.25.3 Evaxion Biotech Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  149. 12.25.4 Evaxion Biotech Artificial Intelligence in Drug Discovery Product Portfolio
  150. 12.25.5 Evaxion Biotech Recent Developments
  151. 12.26 Aria Pharmaceuticals, Inc
  152. 12.26.1 Aria Pharmaceuticals, Inc Company Information
  153. 12.26.2 Aria Pharmaceuticals, Inc Business Overview
  154. 12.26.3 Aria Pharmaceuticals, Inc Revenue in Artificial Intelligence in Drug Discovery Business (2021-2026)
  155. 12.26.4 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Product Portfolio
  156. 12.26.5 Aria Pharmaceuticals, Inc Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst